Work

Preliminary Results of a Phase 1b Study (GP28331) Combining GDC-0199 (ABT-199) and Obinutuzumab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.4687.4687

Authors: Ian Flinn, Mark Brunvand, Martin JS Dyer, Peter Hillman, Jeffrey Jones, James Lymp, Mostafa Elhamy, Gregory Vosganian, Jane Huang, Thomas J. Kipps

Institutions: Sarah Cannon, Colorado Blood Cancer Institute, University of Leicester, St James's University Hospital, The Ohio State University, Genentech, University of California San Diego

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2471323617

FWCI: 3.596

Cites:

Cited by: 26

Related to: 10